<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" bill-type="olc" dms-id="A1" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 S849 IS: Advancing Research for Neurological Diseases Act of 2015</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2015-03-24</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>114th CONGRESS</congress><session>1st Session</session><legis-num>S. 849</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20150324">March 24, 2015</action-date><action-desc><sponsor name-id="S305">Mr. Isakson</sponsor> (for himself, <cosponsor name-id="S364">Mr. Murphy</cosponsor>, <cosponsor name-id="S299">Mr. Vitter</cosponsor>, <cosponsor name-id="S309">Mr. Casey</cosponsor>, and <cosponsor name-id="S318">Mr. Wicker</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To amend the Public Health Service Act to provide for systematic data collection and analysis and
			 epidemiological research regarding Multiple Sclerosis (MS), Parkinson’s
			 disease, and other neurological diseases.</official-title></form>
	<legis-body id="H2228B9177C114B7EA6FEE0AF162B587C" style="OLC">
 <section id="H329E0107723A4EFFB26C52CE650948BF" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Advancing Research for Neurological Diseases Act of 2015</short-title></quote>.</text> </section><section id="H87A4AFC6C1534E7DBEFA84CC0CBD69C8"><enum>2.</enum><header>National neurological diseases surveillance system</header><text display-inline="no-display-inline">Part P of title III of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/280g">42 U.S.C. 280g et seq.</external-xref>) is amended by adding at the end the following:</text>
			<quoted-block display-inline="no-display-inline" id="HA55C9D9C398246F7B39748C892F47284" style="OLC">
				<section id="H8A0DBBD6867A46E9B729C24E9EFC069B"><enum>399V–6</enum><header>Surveillance of neurological diseases</header>
 <subsection commented="no" id="H71D32F6A212B48B3975A8E07266C3282"><enum>(a)</enum><header>In general</header><text>The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall—</text>
 <paragraph commented="no" id="H4B46BEBB3C85466F9083DB8D6A9D6F56"><enum>(1)</enum><text>enhance and expand infrastructure and activities to track the epidemiology of neurological diseases, including multiple sclerosis and Parkinson’s disease; and</text>
 </paragraph><paragraph commented="no" id="H1021F18FEC0640289FF19EE570320542"><enum>(2)</enum><text>incorporate information obtained through such activities into a statistically sound, scientifically credible, integrated surveillance system, to be known as the National Neurological Diseases Surveillance System.</text>
 </paragraph></subsection><subsection commented="no" id="HD075CAB0EE774BAC82AC1174A44F15D2"><enum>(b)</enum><header>Research</header><text>The Secretary shall ensure that the National Neurological Diseases Surveillance System is designed in a manner that facilitates further research on neurological diseases.</text>
 </subsection><subsection id="H64A62BDFD3E2400E833E49414F54D4B1"><enum>(c)</enum><header>Content</header><text>In carrying out subsection (a), the Secretary—</text> <paragraph id="HC09F19C6B5674BF991B733D67AC1662E"><enum>(1)</enum><text>shall provide for the collection and storage of information on the incidence and prevalence of neurological diseases in the United States;</text>
 </paragraph><paragraph commented="no" id="HBF3AD69FEBFF4270BFCC61415F56E769"><enum>(2)</enum><text>to the extent practicable, shall provide for the collection and storage of other available information on neurological diseases, such as information concerning—</text>
 <subparagraph commented="no" id="HFC11EE8F5CDB49BF95E49CC3ECBBEAC5"><enum>(A)</enum><text>demographics and other information associated or possibly associated with neurological diseases, such as age, race, ethnicity, sex, geographic location, and family history;</text>
 </subparagraph><subparagraph commented="no" id="HBB337C93C88F42B68E913078E7F33D3D"><enum>(B)</enum><text>risk factors associated or possibly associated with neurological diseases, including genetic and environmental risk factors; and</text>
 </subparagraph><subparagraph commented="no" id="HF9239E9D1DDF461FBFFDD356B11A7A45"><enum>(C)</enum><text>diagnosis and progression markers;</text> </subparagraph></paragraph><paragraph id="HADEFCB7723D74B378C2A2136277977B3"><enum>(3)</enum><text display-inline="yes-display-inline">may provide for the collection and storage of information relevant to analysis on neurological diseases, such as information concerning—</text>
 <subparagraph id="HBAF5EDB8F12C48CD870CFDBA9B3DAF59"><enum>(A)</enum><text>the epidemiology of the diseases;</text> </subparagraph><subparagraph id="H85FA349853DA424381471DB3EEE149F1"><enum>(B)</enum><text>the natural history of the diseases;</text>
 </subparagraph><subparagraph id="HDC359B43CE3B4CDBB8E883AE4C834F5E"><enum>(C)</enum><text>the prevention of the diseases;</text> </subparagraph><subparagraph id="H315AFC41C5904B619399FA4B2B11B83A"><enum>(D)</enum><text>the detection, management, and treatment approaches for the diseases; and</text>
 </subparagraph><subparagraph id="HB4A0E1A0BA304A82874F605EC9CC08DA"><enum>(E)</enum><text>the development of outcomes measures; and</text> </subparagraph></paragraph><paragraph id="H4A53C15073F844239505DD7C34FB44AA"><enum>(4)</enum><text>may address issues identified during the consultation process under subsection (d).</text>
 </paragraph></subsection><subsection id="HD64EC3E7D9244481AB7777D0E4BD59A5"><enum>(d)</enum><header>Consultation</header><text>In carrying out this section, the Secretary shall consult with individuals with appropriate expertise, including—</text>
 <paragraph id="HF06D1A111ACE4F3387E817339F7879A8"><enum>(1)</enum><text>epidemiologists with experience in disease surveillance or registries;</text> </paragraph><paragraph id="H3AA6155A65EC44D4ACFC76BFE7841FCC"><enum>(2)</enum><text>representatives of national voluntary health associations that—</text>
 <subparagraph id="HC3853637C7714C10B19C9C4D93403F5D"><enum>(A)</enum><text>focus on neurological diseases, including multiple sclerosis and Parkinson’s disease; and</text> </subparagraph><subparagraph id="HF9032AC327964935902B3D08E28A973A"><enum>(B)</enum><text>have demonstrated experience in research, care, or patient services;</text>
 </subparagraph></paragraph><paragraph id="H2A34C403BAF54E4CABF59074029AD0E3"><enum>(3)</enum><text>health information technology experts or other information management specialists;</text> </paragraph><paragraph id="H096B9C6E9F324CFDB2D012B38CE9BF75"><enum>(4)</enum><text>clinicians with expertise in neurological diseases; and</text>
 </paragraph><paragraph id="H71D36EC463F0420FB81B7F55ED5CCAE4"><enum>(5)</enum><text>research scientists with experience conducting translational research or utilizing surveillance systems for scientific research purposes.</text>
 </paragraph></subsection><subsection id="H0966827ECC1D423D86F0A6AA0932C70E"><enum>(e)</enum><header>Grants</header><text>The Secretary may award grants to, or enter into contracts or cooperative agreements with, public or private nonprofit entities to carry out activities under this section.</text>
 </subsection><subsection id="HC48D3BE36BE543DC950A2400BBEEE1AA"><enum>(f)</enum><header>Coordination with other Federal agencies</header><text>Subject to subsection (h), the Secretary shall make information and analysis in the National Neurological Diseases Surveillance System available, as appropriate, to Federal departments and agencies, such as the National Institutes of Health, the Food and Drug Administration, the Centers for Medicare &amp; Medicaid Services, the Agency for Healthcare Research and Quality, the Department of Veterans Affairs, and the Department of Defense.</text>
 </subsection><subsection id="H946C9AC21523412E9968652D36A60B43"><enum>(g)</enum><header>Public access</header><text>Subject to subsection (h), the Secretary shall make information and analysis in the National Neurological Diseases Surveillance System available, as appropriate, to the public, including researchers.</text>
 </subsection><subsection id="H1591FF0BDFD34624B51E8F058479F36C"><enum>(h)</enum><header>Privacy</header><text display-inline="yes-display-inline">The Secretary shall ensure that privacy and security protections applicable to the National Neurological Diseases Surveillance System are at least as stringent as the privacy and security protections under HIPAA privacy and security law (as defined in section 3009(a)(2)).</text>
 </subsection><subsection id="H3E5A36CFF0B24B71BDEE330EB5843F83"><enum>(i)</enum><header>Report</header><text>Not later than 4 years after the date of the enactment of this section, the Secretary shall submit a report to the Congress concerning the implementation of this section. Such report shall include information on—</text>
 <paragraph id="H1EDDEFD8F263441B85512363555D3D6F"><enum>(1)</enum><text>the development and maintenance of the National Neurological Diseases Surveillance System;</text> </paragraph><paragraph id="HF332A8C669894ED2B32BFC21E52DAD77"><enum>(2)</enum><text>the type of information collected and stored in the System;</text>
 </paragraph><paragraph id="H931B8CC429424E0886367AEDD57C53E3"><enum>(3)</enum><text>the use and availability of such information, including guidelines for such use; and</text> </paragraph><paragraph id="H095DACBE2A0B414A92B0FA68B3392207"><enum>(4)</enum><text>the use and coordination of databases that collect or maintain information on neurological diseases.</text>
 </paragraph></subsection><subsection id="H9BCD5E9824C449A1A16144C6D2944D06"><enum>(j)</enum><header>Definition</header><text>In this section, the term <term>national voluntary health association</term> means a national nonprofit organization with chapters, other affiliated organizations, or networks in States throughout the United States.</text>
 </subsection><subsection id="H493752F370C44804893D816F37D525DE"><enum>(k)</enum><header>Authorization of appropriations</header><text>To carry out this section, there is authorized to be appropriated $5,000,000 for each of fiscal years 2015 through 2019.</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></section></legis-body></bill>


